Thomas Civik is chief executive officer and chairman of Pyxis Oncology, appointed in September 2026. He was previously president and chief executive officer of Five Prime Therapeutics and chief commercial officer of Foundation Medicine.
Facts compiled by Executive Moves from publicly available news and press releases on 9 September 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Light profile · auto-generated
Are you Thomas Civik?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →
